I M Lako1, K Taxis, R Bruggeman, H Knegtering, H Burger, D Wiersma, C J Slooff. 1. Rob Giel Research Center (RGOc), Department of Psychiatry (UCP), University Medical Center Groningen (UMCG), University of Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands.
Abstract
BACKGROUND: Antidepressants are frequently prescribed in patients with psychotic disorders, but little is known about their effects in routine clinical practice. The objective was to investigate the prescribing patterns of antidepressants in relation to the course of depressive symptoms in patients with psychotic disorders. METHODS: A cohort of 214 Dutch patients with psychotic disorders received two assessments of somatic and psychiatric health, including a clinician-rated screening for depressive symptoms, as part of annual routine outcome monitoring. RESULTS: Depressive symptoms were prevalent among 43% (93) of the patients. Antidepressants were prescribed for 40% (86) of the patients and the majority 83% (71) continued this therapy after one year. Multivariable analysis showed that patients with more severe psychopathology had a higher risk to develop depressive symptoms the following year (OR [95% CI]=0.953 [0.912-0.995]). For patients with depressive symptoms at baseline, polypharmacy was a potential risk factor to keep having depressive symptoms (OR [95% CI]=1.593 [1.123-2.261]). Antidepressant use was not an independent predictor in both analyses. CONCLUSIONS: Routine outcome monitoring in patients with psychotic disorders revealed a high prevalence of depressive symptoms. Antidepressants were frequently prescribed and continued in routine clinical practice.
BACKGROUND: Antidepressants are frequently prescribed in patients with psychotic disorders, but little is known about their effects in routine clinical practice. The objective was to investigate the prescribing patterns of antidepressants in relation to the course of depressive symptoms in patients with psychotic disorders. METHODS: A cohort of 214 Dutch patients with psychotic disorders received two assessments of somatic and psychiatric health, including a clinician-rated screening for depressive symptoms, as part of annual routine outcome monitoring. RESULTS:Depressive symptoms were prevalent among 43% (93) of the patients. Antidepressants were prescribed for 40% (86) of the patients and the majority 83% (71) continued this therapy after one year. Multivariable analysis showed that patients with more severe psychopathology had a higher risk to develop depressive symptoms the following year (OR [95% CI]=0.953 [0.912-0.995]). For patients with depressive symptoms at baseline, polypharmacy was a potential risk factor to keep having depressive symptoms (OR [95% CI]=1.593 [1.123-2.261]). Antidepressant use was not an independent predictor in both analyses. CONCLUSIONS: Routine outcome monitoring in patients with psychotic disorders revealed a high prevalence of depressive symptoms. Antidepressants were frequently prescribed and continued in routine clinical practice.
Authors: Sandeep Grover; Ajit Avasth; Kamal Kalita; P K Dalal; G P Rao; R K Chadda; Bhavesh Lakdawala; Govind Bang; Kaustav Chakraborty; Sudhir Kumar; P K Singh; Puneet Kathuria; M Thirunavukarasu; P S V N Sharma; T Harish; Nilesh Shah; Kamla Deka Journal: Indian J Psychiatry Date: 2013-01 Impact factor: 1.759
Authors: Edith J Liemburg; Stynke Castelein; Frank van Es; Anne Neeltje Scholte-Stalenhoef; Gerard van de Willige; Henderikus Smid; Ellen Visser; Henderikus Knegtering; Richard Bruggeman Journal: PLoS One Date: 2014-11-20 Impact factor: 3.240
Authors: Nasrettin Sönmez; Kristin Lie Romm; Ole A Andreasssen; Ingrid Melle; Jan Ivar Røssberg Journal: BMC Psychiatry Date: 2013-04-05 Impact factor: 3.630
Authors: Irene M Lako; Johanna T W Wigman; Rianne M C Klaassen; Cees J Slooff; Katja Taxis; Agna A Bartels-Velthuis Journal: BMC Psychiatry Date: 2014-09-03 Impact factor: 3.630